Alkermes plc. Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised
Alkermes plc. (ALKS) reported Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised of $42.01 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions · last filed 2026-07-28
- Alkermes plc. proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2026-06-30 was $26.29M, a 1162.22% increase year-over-year.
- Alkermes plc. proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2026-03-31 was $15.71M, a 46.78% decline year-over-year.
- Alkermes plc. proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2025-12-31 was $11.18M, a 36.02% increase year-over-year.
- Alkermes plc. proceeds, issuance of shares, share-based payment arrangement, including option exercised for the quarter ending 2025-09-30 was $622.00K, a 88.73% decline year-over-year.
- Alkermes plc. proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2025 was $43.41M, a 57.45% increase from fiscal 2024.
- Alkermes plc. proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2024 was $27.57M, a 64.51% increase from fiscal 2023.
- Alkermes plc. proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2023 was $16.76M, a 14.62% decline from fiscal 2022.
- Alkermes plc. proceeds, issuance of shares, share-based payment arrangement, including option exercised for fiscal 2022 was $19.63M, a 22.47% decline from fiscal 2021.
| Period end | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 3 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 6 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 6 month as first filed | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 9 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 9 month as first filed | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 12 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $26.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $42.01M 10-Q · filed 2026-07-28 | $53.18M derived: sum of 3 quarters · filed 2026-07-28 | $53.81M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2026-03-31 | $15.71M 10-Q · filed 2026-05-05 | $26.89M derived: sum of 2 quarters · filed 2026-05-05 | $27.51M derived: sum of 3 quarters · filed 2026-05-05 | $29.60M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-12-31 | $11.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $11.80M derived: sum of 2 quarters · filed 2026-02-25 | $13.88M derived: sum of 3 quarters · filed 2026-07-28 | $43.41M 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $622.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $2.71M derived: sum of 2 quarters · filed 2026-07-28 | $32.23M 10-Q · filed 2025-10-28 | $40.45M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-06-30 | $2.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28 | $31.61M 10-Q · filed 2026-07-28 | $39.83M derived: sum of 3 quarters · filed 2026-07-28 | $45.35M derived: sum of 4 quarters · filed 2026-07-28 | |||
| 2025-03-31 | $29.53M 10-Q · filed 2026-05-05 | $37.75M derived: sum of 2 quarters · filed 2026-05-05 | $43.27M derived: sum of 3 quarters · filed 2026-05-05 | $45.87M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2024-12-31 | $8.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $13.74M derived: sum of 2 quarters · filed 2026-02-25 | $16.35M derived: sum of 3 quarters · filed 2026-02-25 | $27.57M 10-K · filed 2026-02-25 | |||
| 2024-09-30 | $5.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $8.13M derived: sum of 2 quarters · filed 2025-10-28 | $19.35M 10-Q · filed 2025-10-28 | $21.00M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-06-30 | $2.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $13.83M 10-Q · filed 2025-07-29 | $15.48M derived: sum of 3 quarters · filed 2026-02-25 | $18.59M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-03-31 | $11.23M 10-Q · filed 2025-05-01 | $12.87M derived: sum of 2 quarters · filed 2026-02-25 | $15.99M derived: sum of 3 quarters · filed 2026-02-25 | $25.11M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.76M derived: sum of 2 quarters · filed 2026-02-25 | $13.89M derived: sum of 3 quarters · filed 2026-02-25 | $16.76M 10-K · filed 2026-02-25 | |||
| 2023-09-30 | $3.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24 | $12.24M derived: sum of 2 quarters · filed 2024-10-24 | $15.11M 10-Q · filed 2024-10-24 | $15.89M derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2023-06-30 | $9.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-24 | $12.00M 10-Q · filed 2024-07-24 | $12.78M derived: sum of 3 quarters · filed 2025-02-12 | $13.64M derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2023-03-31 | $2.87M 10-Q · filed 2024-05-01 | $3.65M derived: sum of 2 quarters · filed 2025-02-12 | $4.51M derived: sum of 3 quarters · filed 2025-02-12 | $20.71M derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2022-12-31 | $780.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $1.64M derived: sum of 2 quarters · filed 2025-02-12 | $17.84M derived: sum of 3 quarters · filed 2025-02-12 | $19.63M 10-K · filed 2025-02-12 | |||
| 2022-09-30 | $858.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $17.05M derived: sum of 2 quarters · filed 2023-10-25 | $18.85M 10-Q · filed 2023-10-25 | $19.36M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-06-30 | $16.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $17.99M 10-Q · filed 2023-07-26 | $18.50M derived: sum of 3 quarters · filed 2024-02-21 | $22.81M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2022-03-31 | $1.79M 10-Q · filed 2023-04-26 | $2.30M derived: sum of 2 quarters · filed 2024-02-21 | $6.62M derived: sum of 3 quarters · filed 2024-02-21 | $25.06M derived: sum of 4 quarters · filed 2024-02-21 | |||
| 2021-12-31 | $509.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $4.82M derived: sum of 2 quarters · filed 2024-02-21 | $23.27M derived: sum of 3 quarters · filed 2024-02-21 | $25.32M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | $4.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $22.76M derived: sum of 2 quarters · filed 2022-11-02 | $24.81M 10-Q · filed 2022-11-02 | $25.46M derived: sum of 4 quarters · filed 2023-02-16 | |||
| 2021-06-30 | $18.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $20.50M 10-Q · filed 2022-07-27 | $21.15M derived: sum of 3 quarters · filed 2023-02-16 | $21.95M derived: sum of 4 quarters · filed 2023-02-16 | |||
| 2021-03-31 | $2.05M 10-Q · filed 2022-04-27 | $2.71M derived: sum of 2 quarters · filed 2023-02-16 | $3.51M derived: sum of 3 quarters · filed 2023-02-16 | $7.36M derived: sum of 4 quarters · filed 2023-02-16 | |||
| 2020-12-31 | $654.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $1.45M derived: sum of 2 quarters · filed 2023-02-16 | $5.30M derived: sum of 3 quarters · filed 2023-02-16 | $8.37M 10-K · filed 2023-02-16 | |||
| 2020-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $4.65M derived: sum of 2 quarters · filed 2021-10-27 | $7.72M 10-Q · filed 2021-10-27 | $10.26M derived: sum of 4 quarters · filed 2022-02-16 | |||
| 2020-06-30 | $3.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | $6.92M 10-Q · filed 2021-07-28 | $9.46M derived: sum of 3 quarters · filed 2022-02-16 | $13.24M derived: sum of 4 quarters · filed 2022-02-16 | |||
| 2020-03-31 | $3.07M 10-Q · filed 2021-04-28 | $5.61M derived: sum of 2 quarters · filed 2022-02-16 | $9.39M derived: sum of 3 quarters · filed 2022-02-16 | $11.44M derived: sum of 4 quarters · filed 2022-02-16 | |||
| 2019-12-31 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $6.32M derived: sum of 2 quarters · filed 2022-02-16 | $8.37M derived: sum of 3 quarters · filed 2022-02-16 | $18.93M 10-K · filed 2022-02-16 | |||
| 2019-09-30 | $3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $5.83M derived: sum of 2 quarters · filed 2020-10-29 | $16.38M 10-Q · filed 2020-10-29 | $18.94M derived: sum of 4 quarters · filed 2021-02-11 | |||
| 2019-06-30 | $2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $12.61M 10-Q · filed 2020-07-29 | $15.17M derived: sum of 3 quarters · filed 2021-02-11 | $16.48M derived: sum of 4 quarters · filed 2021-02-11 | |||
| 2019-03-31 | $10.55M 10-Q · filed 2020-04-29 | $13.11M derived: sum of 2 quarters · filed 2021-02-11 | $14.43M derived: sum of 3 quarters · filed 2021-02-11 | $18.27M derived: sum of 4 quarters · filed 2021-02-11 | |||
| 2018-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | $3.88M derived: sum of 2 quarters · filed 2021-02-11 | $7.71M derived: sum of 3 quarters · filed 2021-02-11 | $20.88M 10-K · filed 2021-02-11 | |||
| 2018-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-23 | $5.15M derived: sum of 2 quarters · filed 2019-10-23 | $18.32M 10-Q · filed 2019-10-23 | $23.54M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-06-30 | $3.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | $17.00M 10-Q · filed 2019-07-25 | $22.22M derived: sum of 3 quarters · filed 2020-02-13 | $24.11M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2018-03-31 | $13.16M 10-Q · filed 2019-04-25 | $18.38M derived: sum of 2 quarters · filed 2020-02-13 | $20.28M derived: sum of 3 quarters · filed 2020-02-13 | $29.57M derived: sum of 4 quarters · filed 2020-02-13 | |||
| 2017-12-31 | $5.22M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | $7.11M derived: sum of 2 quarters · filed 2020-02-13 | $16.40M derived: sum of 3 quarters · filed 2020-02-13 | $23.52M 10-K · filed 2020-02-13 | |||
| 2017-09-30 | $1.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-23 | $11.18M derived: sum of 2 quarters · filed 2018-10-23 | $18.30M 10-Q · filed 2018-10-23 | $25.86M derived: sum of 4 quarters · filed 2019-02-15 | |||
| 2017-06-30 | $9.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $16.40M 10-Q · filed 2018-07-26 | $23.97M derived: sum of 3 quarters · filed 2019-02-15 | $29.22M derived: sum of 4 quarters · filed 2019-02-15 | |||
| 2017-03-31 | $7.11M 10-Q · filed 2018-04-26 | $14.68M derived: sum of 2 quarters · filed 2019-02-15 | $19.93M derived: sum of 3 quarters · filed 2019-02-15 | $23.92M derived: sum of 4 quarters · filed 2019-02-15 | |||
| 2016-12-31 | $7.56M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $12.82M derived: sum of 2 quarters · filed 2019-02-15 | $16.81M derived: sum of 3 quarters · filed 2019-02-15 | $20.31M 10-K · filed 2019-02-15 | |||
| 2016-09-30 | $5.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $9.25M derived: sum of 2 quarters · filed 2017-10-26 | $12.75M 10-Q · filed 2017-10-26 | $26.08M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2016-06-30 | $3.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-27 | $7.49M 10-Q · filed 2017-07-27 | $20.83M derived: sum of 3 quarters · filed 2018-02-16 | $30.62M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2016-03-31 | $3.50M 10-Q · filed 2017-04-27 | $16.83M derived: sum of 2 quarters · filed 2018-02-16 | $26.63M derived: sum of 3 quarters · filed 2018-02-16 | $34.87M derived: sum of 4 quarters · filed 2018-02-16 | |||
| 2015-12-31 | $13.34M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $23.13M derived: sum of 2 quarters · filed 2018-02-16 | $31.37M derived: sum of 3 quarters · filed 2018-02-16 | $44.97M 10-K · filed 2018-02-16 | |||
| 2015-09-30 | $9.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $18.04M derived: sum of 2 quarters · filed 2016-11-02 | $31.63M 10-Q · filed 2016-11-02 | $51.78M derived: sum of 4 quarters · filed 2017-02-17 | |||
| 2015-06-30 | $8.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | $21.84M 10-Q · filed 2016-07-28 | $41.98M derived: sum of 3 quarters · filed 2017-02-17 | $47.59M derived: sum of 4 quarters · filed 2017-02-17 | |||
| 2015-03-31 | $13.60M 10-Q · filed 2016-04-28 | $33.74M derived: sum of 2 quarters · filed 2017-02-17 | $39.35M derived: sum of 3 quarters · filed 2017-02-17 | $50.15M derived: sum of 4 quarters · filed 2017-02-17 | |||
| 2014-12-31 | $20.15M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $25.76M derived: sum of 2 quarters · filed 2017-02-17 | $36.55M derived: sum of 3 quarters · filed 2017-02-17 | $47.58M 10-K · filed 2017-02-17 | |||
| 2014-09-30 | $5.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $16.40M derived: sum of 2 quarters · filed 2015-10-29 | $27.43M 10-Q · filed 2015-10-29 | $42.56M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2014-06-30 | $10.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-30 | $21.82M 10-Q · filed 2015-07-30 | $36.95M derived: sum of 3 quarters · filed 2016-02-25 | $55.82M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2014-03-31 | $11.03M 10-Q · filed 2015-04-30 | $26.16M derived: sum of 2 quarters · filed 2016-02-25 | $45.03M derived: sum of 3 quarters · filed 2016-02-25 | $60.10M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2013-12-31 | $15.13M derived: 10-K 9 month − 10-Q 6 month · filed 2016-02-25 | $34.00M derived: sum of 2 quarters · filed 2016-02-25 | $49.08M 10-K · filed 2016-02-25 | $65.92M derived: sum of 4 quarters · filed 2016-02-25 | |||
| 2013-09-30 | $18.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-31 | $33.94M 10-Q · filed 2013-10-31 | $50.79M 10-Q · filed 2014-10-29 | $58.57M derived: sum of 4 quarters · filed 2014-04-30 | |||
| 2013-06-30 | $15.08M 10-Q · filed 2013-07-25 | $31.93M 10-Q · filed 2014-07-31 | $39.71M derived: sum of 3 quarters · filed 2014-04-30 | $48.10M derived: sum of 4 quarters · filed 2014-04-30 | |||
| 2013-03-31 | $16.85M 10-Q · filed 2014-04-30 | $24.63M derived: sum of 2 quarters · filed 2014-04-30 | $33.02M derived: sum of 3 quarters · filed 2014-04-30 | $34.36M 10-K · filed 2015-02-24 | |||
| 2012-12-31 | $7.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31 | $16.17M derived: sum of 2 quarters · filed 2013-10-31 | $17.51M 10-Q · filed 2013-01-31 | $21.80M derived: sum of 4 quarters · filed 2014-02-27 | |||
| 2012-09-30 | $8.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-31 | $9.73M 10-Q · filed 2013-10-31 | $14.02M derived: sum of 3 quarters · filed 2014-02-27 | $15.27M derived: sum of 4 quarters · filed 2014-02-27 | |||
| 2012-06-30 | $1.34M 10-Q · filed 2013-07-25 | $5.63M derived: sum of 2 quarters · filed 2014-02-27 | $6.88M derived: sum of 3 quarters · filed 2014-02-27 | $10.38M derived: sum of 4 quarters · filed 2014-02-27 | |||
| 2012-03-31 | $4.29M derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27 | $5.54M derived: sum of 2 quarters · filed 2014-02-27 | $9.04M derived: sum of 3 quarters · filed 2014-02-27 | $20.86M 10-KT · filed 2014-02-27 | $17.19M 10-K · filed 2012-05-18 | ||
| 2011-12-31 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-01-31 | $4.75M derived: sum of 2 quarters · filed 2013-01-31 | $16.57M 10-Q · filed 2013-01-31 | $13.05M 10-Q · filed 2012-02-02 | $20.75M derived: sum of 4 quarters · filed 2013-05-23 | ||
| 2011-09-30 | $3.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-01 | $15.33M 10-Q · filed 2012-11-01 | $12.22M 10-Q · filed 2011-11-03 | $19.50M derived: sum of 3 quarters · filed 2013-05-23 | $20.13M derived: sum of 4 quarters · filed 2013-05-23 | ||
| 2011-06-30 | $11.82M 10-Q · filed 2012-07-26 | $16.00M derived: sum of 2 quarters · filed 2013-05-23 | $16.63M derived: sum of 3 quarters · filed 2013-05-23 | ||||
| 2011-03-31 | $4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-23 | $4.80M derived: sum of 2 quarters · filed 2013-05-23 | $6.16M 10-K · filed 2013-05-23 | $4.74M 10-K · filed 2012-05-18 | |||
| 2010-12-31 | $628.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-02 | $1.98M 10-Q · filed 2012-02-02 | |||||
| 2010-09-30 | $1.35M 10-Q · filed 2011-11-03 | ||||||
| 2010-03-31 | $2.59M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |